# OnCo record ezra-cohen (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ezra-cohen/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ezra-cohen" ;
  schema:name "Ezra E. W. Cohen"@en ;
  schema:description "Led KEYNOTE-040, which showed pembrolizumab improves survival in previously treated head and neck cancer."@en ;
  schema:url <https://onco.cc/people/ezra-cohen/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Cohen%20EEW%5BAuthor%5D%20head%20neck%20pembrolizumab> ;
  onco:tag "head-and-neck", "immunotherapy" ;
  schema:jobTitle "Professor of Medicine and Chief of Hematology-Oncology, UC San Diego Moores Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-9872-6242> ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/ucsd-moores/> ;
  onco:journals <https://onco.cc/journals/jitc/> ;
  schema:affiliation <https://onco.cc/institutions/ucsd-moores/> .